
- ONCOLOGY Vol 13 No 9
- Volume 13
- Issue 9
Oncologists Likely to Get Small Medicare Increases
Anyone who remembers the bruising political battle in 1997-1998over how Medicare would develop “resource-based” practice expenses can breathe a sign of relief over what is likely to be the painless shift to resource-based malpractice
Anyone who remembers the bruising political battle in 1997-1998over how Medicare would develop resource-based practice expenses can breathe a sign of relief over what is likely to be the painless shift to resource-based malpractice expenses. Medicare will work them into its payment formula starting January 1, 2000. That formula takes into account three relative value units (RVUs): for work (accounts for 54.5% of the total payment), practice expense (42.3%), and malpractice expense (3.2%). These three RVUs are added together and then multiplied by a conversion factor of $34.73. The fact that malpractice expenses are such a small part of the formula explains why payment for hematology/oncology codes will increase only 0.3 in 2000, which is fairly typical for most specialties. Medicare also wants to refine some of its practice expense RVUs. That would give hematology/oncology a 1% increase in 2002 over what payments would have been otherwise.
Articles in this issue
about 26 years ago
Lowering Drug Prices for Non-Medicare Patientsabout 26 years ago
Paclitaxel Improves Survival in Metastatic Breast Cancerabout 26 years ago
FDA Plans Crackdown on Online Drug Salesabout 26 years ago
p53 Gene Therapy Shows Activity Against Head and Neck Cancerabout 26 years ago
OTC Analgesic Gel Treats Oral Ulcers in Chemotherapy Patientsabout 26 years ago
September Is Gynecologic Cancer Awareness Monthabout 26 years ago
Improving the Chemotherapy Experienceabout 26 years ago
Chemoradiation an Effective But Toxic Therapy for Colorectal Cancerabout 26 years ago
Global Progress: Breast Cancer Mortalityabout 26 years ago
Innovative Clinical Trial for Patients With Advanced Pancreatic CancerNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.


















































































